Assignee
MSN LABORATORIES PRIVATE LTD R&D CENTER
IN·9 granted patents·12 pending applications·9 citations·filing 2017–2023
Top patents by PatentIndex Score
21 records- 0188US11261160B2Process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide, (2S)-hydroxybutanedioate and its polymorphs thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2017·Granted Mar 1, 2022·9 cites·15 claims
- 0268US10913717B2Solid state forms of N-[2-[(I S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methyl sulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-L H-isoindol-4-yl]acetamide and process for preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2019·Granted Feb 9, 2021·0 cites·13 claims
- 0362US2025074882A1Improved process for the preparation of 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-n-(2hydroxyethoxy)-1-methyl-1h-benzimidazole-6-carboxamideMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2023·Application pending·0 cites
- 0460US2025074912A1Improved process for the preparation of upadacitinibMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2023·Application pending·0 cites
- 0558US2026042809A1Process for the preparation of semaglutideMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2022·Application pending·0 cites
- 0658US2024327352A1Novel process for the preparation of 1-(2-{4-[(4-carbamoylpiperidin-1-yl)methyl]- n-methylbenzamido}ethyl)piperidin-4-yl n-({1,1'-biphenyl}-2-yl)carbamateMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2022·Application pending·0 cites
- 0754US12227506B2Crystalline polymorphs of 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one and process for preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Granted Feb 18, 2025·0 cites·12 claims
- 0854US2025230160A1Process for the preparation of 4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluoro-phenyl)-butan-1-one and intermediates thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2023·Application pending·0 cites
- 0953US2023233547A1Pharmaceutocal composition containing n-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-n?-(4-fluorophenly)cyclopropane-1,1-dicarboxamide, (2s)-hydroxybutanedioateMSN LABORATORIES PRIVATE LTD R & D CENTER·Filed 2021·Application pending·0 cites
- 1052US12473292B2Polymorphs of 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]-amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide and its pharmaceutically acceptable salts and process for the preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Granted Nov 18, 2025·0 cites·7 claims
- 1152US11149026B2Solid state forms of 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione hydrochloride and their processes for the preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2018·Granted Oct 19, 2021·0 cites·13 claims
- 1252US2024300930A1Novel process for the preparation of 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxideMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2022·Application pending·0 cites
- 1351US11434256B2Process for the preparation of 3α,7α-dihydroxy-6α-ethyl-5β-cholan-24-oic acidMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2019·Granted Sep 6, 2022·0 cites·7 claims
- 1451US2025281475A1A pharmaceutical composition of pitolisant hydrochloride and their process for the preparationMSN LABORATORIES PRIVATE LTD R & D CENTER·Filed 2023·Application pending·0 cites
- 1551US2024018152A1Novel process for the preparation of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide or its salts thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2022·Application pending·0 cites
- 1650US11236050B2Polymorphs of 4-[3-chloro-4-(n′-cyclopropyl ureido)phenoxy] -7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2018·Granted Feb 1, 2022·0 cites·12 claims
- 1746US12227518B2Crystalline polymorphs of sodium (4R,12AS)-9-{[(2,4-difluorophenyl) methyl]carbamoyl}-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido [1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-7-olate and process for preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Granted Feb 18, 2025·0 cites·16 claims
- 1846US2020306225A1Stable n-((1r,2r)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl) octanamide (2r,3r)-2,3-dihydroxysuccinate premix and process for preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2018·Application pending·0 cites
- 1946US2022251052A1Improved process for the preparation of 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid or its pharmaceutically acceptable salts and polymorphs thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Application pending·0 cites
- 2045US10865217B2Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2018·Granted Dec 15, 2020·0 cites·10 claims
- 2144US2024279266A1An improved process for the preparation of (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-4-hydroxy-1,3-diazinan-2one and its intermediate compoundsMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MSN LABORATORIES PRIVATE LTD R&D CENTER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →